High-throughput screening identifies non-coding RNA PANC246 as a novel pan-tumor suppressor ncRNA

丁伟峰,张健锋,常仁安,叶敬新,郭士成,曹桂莲
DOI: https://doi.org/10.3760/cma.j.cn421213-20201229-00963
2021-01-01
Abstract:Objective:Non-coding RNA exerted key roles in the occurrence and development of tumors. However, ncRNAs with tumor extensively-suppressing roles were largely undefined. The purpose of this study is to find novel tumor-suppressing ncRNAs and confirm their function by bio-informatics and in vitro experiments.Methods:We applied the genome-widemeta analysis to the pan-cancer RNA-sequencing data across 23 human cancers in The Cancer Genome Atlas (TCGA) database, and screen novel down-regulated pan-cancer ncRNAs. We next performed in vitro experiments including CCK-8, cell migration, Transwell invasion and cell apoptosis to confirm its pan-cancer suppression roles. Bilateral t test was used for comparison between two groups. Results:In this research, we found 1615 differential-expressed ncRNAs. Among these, a novel ncRNA were identified, which encoded by ENSG00000231246 and we nominated it as PAn-cancer Non-Coding RNA 246 (PANC246). Compared to untransfected group and pcDNA3.1 plasmid group, over-expression of PANC246 significantly inhibited the ability of cell proliferation ( t=7.252, P<0.01), migration ( t=15.073, P<0.01) and invasion ( t=11.003, P<0.01), whilst it significantly increased the apoptosis of tumor cells ( t=23.293, P<0.01). Furthermore, up-regulated PANC246 significantly down-regulated the mRNA levels of the related oncogenes, such as CDK2 ( t=19.301, P<0.01), KRAS ( t=14.682, P<0.01), and MUC16 ( t=22.581, P<0.01). Conclusion:PANC246 was a novel pan-cancer suppressor which may be a potential therapeutic target.
What problem does this paper attempt to address?